Back to top
more

Cardinal Health (CAH)

(Real Time Quote from BATS)

$157.38 USD

157.38
939,225

-0.86 (-0.54%)

Updated Aug 6, 2025 03:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value D Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (60 out of 246)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

by Zacks Equity Research

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Zacks Equity Research

RVTY Stock Falls Despite FDA Nod for Automated Testosterone Test

by Zacks Equity Research

Revvity aims to expand the FDA-cleared menu for the EUROIMMUN family of ChLIA automation solutions to serve a wider patient pool.

Zacks Equity Research

Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?

by Zacks Equity Research

Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Zacks Equity Research

WBA Q1 Earnings and Revenues Beat Estimates, Stock Up in Pre-Market

by Zacks Equity Research

Walgreens delivers better-than-expected earnings and revenues in the first quarter of fiscal 2025.

Zacks Equity Research

Here's Why You Should Retain HealthEquity Stock in Your Portfolio Now

by Zacks Equity Research

HQY's sustained strength in HSAs raises optimism about the stock.

Zacks Equity Research

Reasons to Retain The Cooper Companies Stock in Your Portfolio Now

by Zacks Equity Research

COO benefits from strength in its business segments. Its acquisitions are likely to drive the top line. However, a rise in selling, general and administrative expenses is concerning.

Zacks Equity Research

Cardinal Health (CAH) Beats Stock Market Upswing: What Investors Need to Know

by Zacks Equity Research

Cardinal Health (CAH) closed at $122.53 in the latest trading session, marking a +0.93% move from the prior day.

Zacks Equity Research

Here's Why You Should Add Glaukos Stock to Your Portfolio Now

by Zacks Equity Research

GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism.

Zacks Equity Research

Should SPDR Russell 1000 Low Volatility Focus ETF (ONEV) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for ONEV

Zacks Equity Research

Here's Why You Should Add Accuray Stock to Your Portfolio Now

by Zacks Equity Research

ARAY's solid product demand and revenue growth raise optimism about the stock.

Zacks Equity Research

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Equity Research

OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains

by Zacks Equity Research

OPK aims to advance a novel vaccine candidate for EBV infection, provide protective immunity to patients and prevent these diseases.

Zacks Equity Research

Glaukos Reaches 52-Week High: What's Driving the Stock's Rally?

by Zacks Equity Research

Investors are optimistic about GKOS' strength in its product portfolio amid robust demand and expansion in new markets.

Zacks Equity Research

Cardinal Health (CAH) Advances But Underperforms Market: Key Facts

by Zacks Equity Research

The latest trading day saw Cardinal Health (CAH) settling at $119.63, representing a +0.28% change from its previous close.

Zacks Equity Research

BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business

by Zacks Equity Research

Bioventus aims to improve its focus and execution within its core businesses and enhance liquidity following the divestiture.

Zacks Equity Research

Reasons to Add Cardinal Health Stock to Your Portfolio Now

by Zacks Equity Research

CAH continues to grow on the back of its robust product portfolio and a strong quarterly result.

Zacks Equity Research

Reasons to Retain Inari Medical Stock in Your Portfolio for Now

by Zacks Equity Research

NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.

Zacks Equity Research

McKesson Stock Declines Post Divestiture of Canada-Based Businesses

by Zacks Equity Research

MCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms.

Zacks Equity Research

Is Cardinal Health (CAH) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Is SPDR Russell 1000 Low Volatility Focus ETF (ONEV) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for ONEV

Zacks Equity Research

Cardinal Health (CAH) Stock Moves -1.02%: What You Should Know

by Zacks Equity Research

In the most recent trading session, Cardinal Health (CAH) closed at $117.92, indicating a -1.02% shift from the previous trading day.

Zacks Equity Research

Here's Why Cardinal Health (CAH) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Equity Research

Is Xtrackers Russell US Multifactor ETF (DEUS) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for DEUS

Zacks Equity Research

Should Xtrackers Russell US Multifactor ETF (DEUS) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for DEUS

Zacks Equity Research

Cardinal Health (CAH) Rises Yet Lags Behind Market: Some Facts Worth Knowing

by Zacks Equity Research

Cardinal Health (CAH) reachead $118.83 at the closing of the latest trading day, reflecting a +0.41% change compared to its last close.